文献速递多重用药老年慢病共病管理

基层医生对老年慢性疼痛患者阿片类药物减处方的定性分析

Primary Care Practitioners' Approaches to Deprescribing Opioids for Older Adults With Chronic Pain: A Qualitative Analysis.
PubMed 文献 · J Am Geriatr Soc · 2026-04-08

该研究通过对马萨诸塞州某医疗系统18名基层医生进行半结构化访谈,使用三个假设临床病例(低、中、高风险)探讨其对老年慢性疼痛患者阿片类药物减处方的态度与方法。多数医生会启动减处方对话,但方法因风险而异;高风险病例中部分医生因担忧心理健康和非法阿片使用而犹豫,纳洛酮推荐不频繁。结论认为医生对阿片使用障碍迹象的管理信心不足,需额外支持。

要点

  • 超半数基层医生会在三个风险病例中启动阿片减处方对话。
  • 低中风险病例强调患者主导的减量计划与阿片风险教育。
  • 高风险病例中约半数建议阿片使用障碍药物治疗,纳洛酮推荐不频繁。

核心结论

  • 基层医生常会启动老年阿片减处方对话,但对有阿片使用障碍迹象者管理信心较低。
  • 医生需要额外支持以成功实施老年阿片减处方对话。

研究设计与样本

  • 对马萨诸塞州某医疗系统18名基层医生进行半结构化访谈,使用低、中、高三个假设临床病例。

主要发现

  • 超过半数基层医生在三个病例中均会启动减处方对话。
  • 低和中风险病例中,医生强调患者主导的减量计划及阿片风险教育。
  • 高风险病例中,部分医生因担忧患者心理健康和非法阿片使用而对启动对话不确定。
  • 纳洛酮在三个病例中均不常被推荐;高风险病例中约半数医生建议阿片使用障碍药物。

临床怎么用

  • 对老年慢性疼痛患者应主动评估阿片减处方需求并启动对话。
  • 低中风险患者可采用患者主导减量计划并加强风险教育。
  • 高风险患者需关注心理健康与非法阿片使用风险,并考虑阿片使用障碍药物及纳洛酮。

局限性

  • 样本仅来自马萨诸塞州一个医疗系统的18名基层医生,结果可能不可推广。
  • 采用假设临床病例访谈,可能不完全反映真实临床行为。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risks related to long-term opioid therapy for chronic pain are high and may increase over time with aging. Deprescribing may be a beneficial intervention for older adults prescribed chronic opioids. METHODS: Semi-structured interviews with hypothetical clinical cases of older adults prescribed opioids for chronic pain: (1) low-risk case: a patient prescribed low-dose opioids without concerns; (2) moderate-risk case: a patient with multimorbidity and concurrent benzodiazepine use prescribed moderate opioid doses; (3) high-risk case: a patient prescribed high-dose opioids with signs of an opioid use disorder (OUD). PCPs were asked, in an open-ended fashion, to discuss whether they would initiate a deprescribing conversation, how they would approach deprescribing, and how they would approach a patient who declined recommendations to deprescribe. PARTICIPANTS AND SETTING: PCPs from a Massachusetts health system. RESULTS: 18 PCPs participated (56% female, 78% academic). More than half of PCPs would initiate a deprescribing conversation across the three cases. PCPs' approach to deprescribing and mitigating risks differed based on clinical risk. In low and moderate-risk cases, PCPs emphasized a patient-directed taper plan and education on opioid risks. In the high-risk case, some PCPs were uncertain about initiating a deprescribing conversation due to concerns about the patient's mental health and the risk of illicit opioid use. Naloxone was infrequently recommended across the three cases, but in the high-risk case, approximately half of PCPs suggested medications for OUD. CONCLUSIONS: PCPs reported that they would often initiate opioid deprescribing conversations with older adults, but were less confident in managing older adults with signs of OUD. PCPs require additional support to implement successful conversations on opioid deprescribing with older adults.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Wang BX, Lindenberg JH, Herzig SJ, et al. Primary Care Practitioners' Approaches to Deprescribing Opioids for Older Adults With Chronic Pain: A Qualitative Analysis. J Am Geriatr Soc. 2026. PMID: 41952328. doi:10.1111/jgs.70438

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。